Valuation Morepen Laboratories Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 11:01:11 24/07/2026 BST			5-day change	1st Jan Change
53.79 ^INR	+2.57%		-8.75%	+30.97%

07-01	Morepen Laboratories Limited Accelerates Manufacturing Expansion, Plans 1,000 KL Reactor Capacity	CI
07-01	Morepen Scales Up CDMO Program, Expects INR 2.25 Billion Supplies in Second Quarter of 2027	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	4,291	14,462	17,488	13,127	21,500	26,220
Change	-	237%	20.93%	-24.94%	63.79%	21.95%
Enterprise Value (EV) ¹	5,486	15,415	18,663	13,162	21,620	26,219
Change	-	180.98%	21.07%	-29.48%	64.27%	21.27%
P/E	12.8x	15x	18.7x	33.4x	22.4x	21.8x
PBR	1.51x	3.4x	3.02x	1.74x	2.54x	2.27x
PEG	-	0x	-2.12x	-0.6x	0x	1.3x
Capitalization / Revenue	0.5x	1.21x	1.12x	0.92x	1.26x	1.45x
EV / Revenue	0.64x	1.29x	1.2x	0.93x	1.27x	1.45x
EV / EBITDA	8.19x	12.5x	13.9x	19.2x	14x	16.2x
EV / EBIT	14.9x	15.7x	15.8x	23.5x	15.8x	18.1x
EV / FCF	-31.9x	-54.9x	-13x	-47.9x	-94x	-11.8x
FCF Yield	-3.13%	-1.82%	-7.71%	-2.09%	-1.06%	-8.51%
Dividend per Share ²	-	-	-	-	-	0.2
Rate of return	-	-	-	-	-	0.42%
EPS ²	0.7465	2.15	1.96	0.77	1.88	2.2
Distribution rate	-	-	-	-	-	9.09%
Net sales ¹	8,584	11,980	15,558	14,220	17,019	18,116
EBITDA ¹	670.3	1,230	1,338	686.6	1,545	1,620
EBIT ¹	369	981.7	1,180	560.8	1,366	1,451
Net income ¹	335.8	970.9	1,017	386.8	961.6	1,180
Net Debt ¹	1,195	953.1	1,174	34.98	120.5	-0.928
Reference price ²	9.54	32.15	36.60	25.68	42.06	47.85
Nbr of stocks (in thousands)	449,826	449,826	477,826	511,169	511,169	547,954
Announcement Date	05/09/20	04/09/21	02/09/22	04/09/23	01/08/24	12/08/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
MOREPEN LABORATORIES LIMITED	-	-	-	-	306M
ELI LILLY AND COMPANY	35.93x	12.68x	26.75x	0.57%	1,067B
JOHNSON & JOHNSON	28.24x	6.45x	17.87x	2.04%	635B
ABBVIE INC.	33.87x	7.65x	15.73x	2.65%	458B
ROCHE HOLDING AG	19.22x	4.69x	11.59x	2.82%	347B
NOVARTIS AG	21.56x	5.71x	14.24x	2.81%	295B
ASTRAZENECA PLC	21.1x	4.45x	12.31x	1.98%	262B
NOVO NORDISK A/S	14.14x	5.26x	10.84x	3.54%	216B
AMGEN INC.	24.66x	6.48x	11.43x	2.68%	203B
GILEAD SCIENCES, INC.	-46.58x	5.59x	30.88x	2.55%	161B
Average	16.90x	6.55x	16.85x	2.4%	364.38B
Weighted average by Cap.	24.95x	7.95x	18.71x	1.96%